Changjiang Securities(000783) 证券之星· Zheng Quan Zhi Xing·2025-05-29 09:57Group 1 - The company, Kaineng Health Technology Group Co., Ltd., has received approval for the issuance of convertible bonds to unspecified objects, with the registration approval dated June 17, 2023 [2] - The bond issuance was approved by the company's board meeting on October 28, 2022, and the third extraordinary general meeting of shareholders on November 15, 2022 [2] - The convertible bonds will be listed on the Shenzhen Stock Exchange, with a maturity date set for July 19, 2029 [2] Group 2 - The company plans to distribute cash dividends of RMB 0.4 per 10 shares (including tax) to all shareholders, with the record date for this distribution set for May 29, 2025 [3][4] - The conversion price of the convertible bonds will be adjusted from RMB 5.4 per share to RMB 5.36 per share effective from May 30, 2025, due to the cash dividend distribution [3][4] - The adjustment of the conversion price is based on the company's profit distribution plan and follows the guidelines outlined in the prospectus [3][4] Group 3 - The company has established a formula for adjusting the conversion price based on various corporate actions, including cash dividends and stock distributions [4] - The adjustment process will be communicated through announcements on the Shenzhen Stock Exchange and other media as required by regulatory authorities [4][5] - The company will ensure that any changes affecting the rights of convertible bondholders will be handled fairly and transparently [5] Group 4 - The adjustments to the conversion price due to the profit distribution plan do not impact the company's daily operations or debt repayment capabilities [6] - The bond trustee, Changjiang Securities, will continue to monitor the repayment of principal and interest on the convertible bonds and other significant matters affecting bondholder rights [7]